Neurogene Inc.
NGNE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $401,583 | $248,523 | $130,545 | $5,306,016 |
| - Cash | $136,586 | $148,210 | $82,021 | $70,544 |
| + Debt | $12,428 | $16,255 | $249,055 | $6,430 |
| Enterprise Value | $277,425 | $116,568 | $297,579 | $5,241,902 |
| Revenue | $925 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2,322 | -$3,262 | -$3,196 | -$42,264 |
| % Margin | -251% | – | – | – |
| EBITDA | -$71,885 | -$52,286 | -$51,991 | -$49,587 |
| % Margin | -7,771.4% | – | – | – |
| Net Income | -$75,144 | -$36,317 | -$55,189 | -$50,517 |
| % Margin | -8,123.7% | – | – | – |
| EPS Diluted | -4.28 | -2.83 | -4.3 | -0.92 |
| % Growth | -51.2% | 34.2% | -367.4% | – |
| Operating Cash Flow | -$70,603 | -$51,422 | -$52,824 | -$46,400 |
| Capital Expenditures | -$808 | -$321 | -$2,230 | -$18,369 |
| Free Cash Flow | -$71,411 | -$51,743 | -$55,054 | -$64,769 |